Real-World Adherence in Patients with Metastatic Colorectal Cancer Treated with Trifluridine plus Tipiracil or Regorafenib.

Oncologist · 2020 · PMC6964129 · PMID 31591140

Europe PMC DOI

hedged sentence

0.3250

closest p · 6.5× alpha

0.3250

boldest claim

The sentences

did not reach statistical significancep = .325not close (p > 0.1)

28.0%; p < .001) but did not reach statistical significance at 6 months of follow‐up (21.4% vs. 16.0%; p = .325).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.